The use of thymosin alpha 1 to reduce the side effects of...

Details The use of thymosin alpha 1 to reduce the side effects of... The use of thymosin alpha 1 to reduce the side effects of...

A - Human Necessities

61

K

A61K 38/22 (2006.01) A61K 31/00 (2006.01) A61K 33/00 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2407238

A method for reducing the severity of chemotherapy side effects in cancer patients by administering thymosin .alpha.1 in conjunction with the administration of a chemotherapy agent to the patient. As a result of the reduction of post-chemotherapy side effects, patients experience an increase in the quality of life.

L'invention porte sur un procédé visant à atténuer la gravité des effets secondaires de la chimiothérapie chez des patients atteints d'un cancer, ce procédé consistant à administrer au patient la thymosine .alpha.¿1? conjointement avec un agent chimiothérapeutique. La réduction des effets secondaires après une chimiothérapie confère au patient une meilleure qualité de vie.

Affiliated with

Also associated with

Rating

The use of thymosin alpha 1 to reduce the side effects of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The use of thymosin alpha 1 to reduce the side effects of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of thymosin alpha 1 to reduce the side effects of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1834684